GlassScriptPhysician profile
David M Anapolle
NPI 1013007418
$776.35
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $13.57 · 2021: $57.31 · 2022: $229 · 2023: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $183.67 | 2023 | Ankle Fracture System |
| Fidia Pharma USA INC. | $111.38 | 2019-2023 | Hyalgan |
| Bioventus LLC | $82.87 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $72.80 | 2022 | |
| Smith+Nephew, INC. | $70.80 | 2019-2021 | |
| Depuy Synthes Sales INC. | $69.70 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $57.90 | 2022-2023 | Seglentis |
| Orthogenrx INC. | $33.29 | 2019-2021 | |
| Si-Bone, INC. | $32.35 | 2023 | |
| Sanofi-Aventis U.S. LLC | $26.37 | 2020-2022 | |
| Trice Medical, INC. | $21.84 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.38 | 2023 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Anapolle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.